Device Trial Radar · NCT03309683
Clip Placement Following Colonic Endoscopic Mucosal Resection (EMR)
Last checked: Nov 19, 2026Latest source record: Mar 30, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
356
Actual
Start
Mar 5, 2018
Primary completion
Aug 19, 2022
Study completion Mar 1, 2023
Sponsor
- Lead sponsor
- Radboud University Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- UMC Utrecht; Maastricht University Medical Center; Erasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Maxima Medical Center; Jeroen Bosch Ziekenhuis; Bernhoven Hospital; Isala; Canisius-Wilhelmina Hospital; Maasstad Hospital; Noordwest Ziekenhuisgroep; Meander Medisch Centrum; Catharina Ziekenhuis Eindhoven; Elisabeth-TweeSteden Ziekenhuis; St Jansdal Hospital; Leiden University Medical Center; Dutch Digestive Diseases Foundation; Franciscus Gasthuis; Bravis Hospital
- First posted
- Oct 13, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study design: A national, multi-center, patient-blinded, randomized clinical trial. Study population: Patients undergoing EMR with a moderate to severe risk (right sided colon, ≥2cm) of developing Delayed Bleeding (DB). Intervention: PC will be compared to standard care (no PC). Main study endpoints: Primary endpoint is the incidence of DB. Secondary endpoints are cost-effectiveness, quality of life and (severe) adverse events related to PC, adenoma recurrence and risk factors for DB.
Conditions
- Polyp, Colonic
- Bleeding
Interventions
Olympus Quick Clip Pro - Single Use Repositionable ClipsDevice
A hemoclip will be placed after every 0,5-1,0 cm of the resected area to proximate wound edges.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Delayed bleedingTime frame: 30 days
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Ziekenhuis St Jansdal
Harderwijk, Gelderland, Netherlands
Radboudumc
Nijmegen, Gelderland, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.